Novateor Research Laboratories
BSE: NOVATEOR
Prev Close
51.77
Open Price
49.19
Volume
3,000
Today Low / High
49.19 / 49.19
52 WK Low / High
30.24 / 57.5
Range
47 - 52
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 49.19, reflecting a change of -2.58 (-4.98358%). The expected target range on the BSE is 47 - 52. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Novateor Research Laboratories Graph
Novateor Research Laboratories Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Novateor Research Laboratories T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 49.19, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 49.19 | 49.68 | 44.71 - 54.65 |
| 50.17 | 40.14 - 60.21 | ||
| 50.67 | 35.47 - 65.87 | ||
| Bearish Scenario | 49.19 | 48.70 | 43.83 - 53.57 |
| 48.21 | 38.56 - 57.85 | ||
| 47.71 | 33.40 - 62.03 |
Overview of Novateor Research Laboratories
ISIN
INE08JY01013
Industry
Medical - Specialties
Vol.Avg
276
Market Cap
297,706,242
Last Dividend
0
Official Website
IPO Date
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
No financial ratio data available.
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial income report data available. | |||||||||||
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial balance sheet data available. | ||||||||||||
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| No annual financial cash flow statement data available. | |||||||||||
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial income report data available. | |||||||||
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial balance sheet data available. | |||||||||
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| No quarterly financial cash flow statement data available. | |||||||||
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Specialties
No stocks found in this industry.
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1978
FAQs about Novateor Research Laboratories
The CEO is Navdeep Subhashbhai Mehta.
The current price is ₹49.19.
The range is ₹30.24-57.5.
The market capitalization is ₹29.77 crores.
The company operates in the Healthcare sector.
Overview of Novateor Research Laboratories (ISIN: INE08JY01013) is a leading Medical - Specialties in India. With a market capitalization of ₹29.77 crores and an average daily volume of 276 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.